
Contact us
About company
Chimeron Bio is combining a first-in-class platform & the science of synthetic genomics to develop a robust portfolio of self-amplifying RNA therapeutics.
US 3675 market street
Unknown
Not verified company
Chimeron Bio is combining a first-in-class platform & the science of synthetic genomics to develop a robust portfolio of self-amplifying RNA therapeutics.